RSS-Feed abonnieren
DOI: 10.3233/JPN-2010-0407
Stroke in sickle cell disease
Authors
Verantwortlicher Herausgeber dieser Rubrik:
Publikationsverlauf
26. Juli 2009
02. September 2009
Publikationsdatum:
30. Juli 2015 (online)

Abstract
Sickle cell disease (SCD) is the second commonest cause of stroke in the pediatric population. Cerebrovascular complications in SCD may involve large or small vessels and present as large infarctions, intracranial or subarachnoid hemorrhage, moyamoya disease or silent infarcts. Predictors of stroke in SCD include high blood flow velocity on transcranial Doppler, low hemoglobin value, absence of alpha-thalassemia, high white cell count, hypertension, silent brain infarction, and a history of chest crisis. Regular blood transfusions are used for primary and secondary prevention of stroke in SCD. Other management strategies include stem cell transplantation,